Question 1

What is MiMedx Group's accounts receivable, credit loss expense (reversal)?

Accepted Answer

MiMedx Group (MDXG) reported accounts receivable, credit loss expense (reversal) of $5.28M in Q2 2026.

Question 2

How has MiMedx Group's accounts receivable, credit loss expense (reversal) changed year-over-year?

Accepted Answer

MiMedx Group's accounts receivable, credit loss expense (reversal) increased by 1404.6% year-over-year, from $351K to $5.28M.

Question 3

What is the long-term trend for MiMedx Group's accounts receivable, credit loss expense (reversal)?

Accepted Answer

Over 3 years (2022 to 2025), MiMedx Group's accounts receivable, credit loss expense (reversal) has grown at a 35.8% compound annual growth rate (CAGR), from $2.6M to $6.52M.


Balance at December 31, 2025	$	$8,703
Credit loss expense	1,464
Write-offs	(629)
Balance at March 31, 2026	$	$9,538
Credit loss expense	5,281
Write-offs	$	$(16)
Balance at June 30, 2026	$	$14,803

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about MiMedx Group's accounts receivable, credit loss expense (reversal).

MiMedx Group MDXG Accounts Receivable, Credit Loss Expense (Reversal)